Reach Us +44-1753-390542
Generations of Sequencing Technologies: From First to Next Generation | OMICS International
ISSN: 0974-8369
Biology and Medicine
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Generations of Sequencing Technologies: From First to Next Generation

Mehdi Kchouk1,3*, Jean-François Gibrat2 and Mourad Elloumi3

1Faculty of Sciences of Tunis (FST), Tunis El-Manar University, Tunisia

2Research Unit Applied Mathematics and Computer Science, from Genomes to the Environment' (MaIAGE), Jouy en Josas, France

3Laboratory of Technologies of Information and Communication and Electrical Engineering, National Superior School of Engineers of Tunis, University of Tunis, Tunisia

*Corresponding Author:
Mehdi Kchouk
Faculty of Sciences of Tunis (FST)
Tunis El-Manar University, Tunisia
Tel: +216 71 872 253
E-mail: [email protected]

Received Date: January 31, 2017; Accepted Date: February 27, 2017; Published Date: March 06, 2017

Citation: Kchouk M, Gibrat JF, Elloumi M (2017) Generations of Sequencing Technologies: From First to Next Generation. Biol Med (Aligarh) 9: 395. doi:10.4172/0974-8369.1000395

Copyright: © 2017 Kchouk M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Biology and Medicine


DNA sequencing process utilizes biochemical methods in order to determine the correct order of nucleotide bases in a DNA macromolecule using sequencing machines. Ten years ago, sequencing was based on a single type of sequencing that is Sanger sequencing. In 2005, Next Generation Sequencing Technologies emerged and changed the view of the analysis and understanding of living beings. Over the last decade, considerable progress has been made on new sequencing machines. In this paper, we present a non-exhaustive overview of the sequencing technologies by beginning with the first methods history used by the commonly used NGS platforms until today. Our goal is to provide beginners in the field as well as to the amateurs of science a simple and understandable description of NGS technologies in order to provide them with basic knowledge as an initiation into this field in full ardor.


Next generation sequencing technologies; DNA; Sequencing; Long reads; Short reads


The discovery of the double helix structure composed of four Deoxyribonucleic Acid (DNA) bases {A, T, C, G} by Watson JD et al. in 1953 [1] has led to the decoding of genomic sequences and know DNA composition of organisms. The DNA sequencing is the discovery that uses the DNA composition to understand and decrypt the code to all biological life on earth as well as to understand and treat genetic diseases [2].

The appearance of sequencing technologies has played an important role in the analysis of genomic sequences of organisms. A DNA sequencer produces files containing DNA sequences [3]. These sequences are strings called reads on an alphabet formed by five letters {A, T, C, G, N}. The symbol N is used to represent an ambiguity. The first sequencing technologies were developed in 1977 by Sanger et al. [4] from Cambridge University awarded a Nobel Prize in chemistry in 1980 and Maxam et al. [5] from Harvard University. Their discovery opened the door to study the genetic code of living beings and brought their inspiration to researchers to the development of faster and efficient sequencing technology. Sanger sequencing has become the most applied technique of sequencing for its high efficiency and low radioactivity [6] and has been commercialized and automated as the "Sanger Sequencing Technology".

Sanger and Maxam-Gilbert sequencing technologies were the most common sequencing technologies used by biologists until the emergence of a new era of sequencing technologies opening new perspectives for genomes exploration and analysis. These sequencing technologies were firstly appeared by Roche’s 454 technology in 2005 [7] and were commercialized as technologies capable of producing sequences with very high throughput and at much lower cost than the first sequencing technologies. These new sequencing technologies are generally known under the name of “Next Generation Sequencing (NGS) Technologies” or “High Throughput Sequencing Technologies”.

NGS technologies produce a massively parallel analysis with a highthroughput from multiple samples at much reduced cost [8]. NGS technologies can be sequenced in parallel millions to billions of reads in a single run and the time required to generate the GigaBase sized reads is only a few days or hours making it best than the first generation sequencing such as Sanger sequencing. The human genome, for example, consists of 3 billion bps and is made up of DNA macromolecules of lengths varying from 33 to ~247 million bps, distributed in the 23 chromosomes located in each human cell nucleus, the sequencing of the human genome using the Sanger sequencing took almost 15 years, required the cooperation of many laboratories around the world and costed approximately 100 million US dollars, whereas the sequencing by NGS sequencers using the 454 Genome Sequencer FLX took two months and for approximately one hundredth of the cost [9]. Unfortunately, NGS are incapable to read the complete DNA sequence of the genome, they are limited to sequence small DNA fragments and generate millions of reads. This limit remains a negative point especially for genome assembly projects because it requires high computing resources.

NGS technologies continue to improve and the number of sequencers increases these last years. However, the literature divided NGS technologies into two types [3,10]. We distinguish the second generation sequencing technologies which refer to the newest sequencing technologies developed in the NGS environment after the first generation [11,12], they are characterized by the need to prepare amplified sequencing banks before starting the sequencing of amplified DNA clones [13] and there are the third generation sequencing technologies that are sequencing technologies recently appeared [6], in contrast to the second generation, these technologies are classified as Single Molecule Sequencing Technology [14] because they can make sequencing a single molecule without the necessity to create the amplification libraries and that are capable of generating longer reads at much lower costs and in a shorter time.

Several previous reports and studies presented the sequencing technologies and detailed chemical mechanisms of each sequencing platform [10,11,13,15-23]. In the following, we present a brief review of the three existing generations of sequencing technologies (the first, second and third). We focus on sequencing methods and platforms characterizing each generation of sequencing (Table 1).

Platform Instrument Reads per run Avg Read length (pb) Read Type Error Type Error Rate (%) Data Generated per run (Gb) Year
First Generation
ABI Sanger 3730xl 96 400 – 900* SE NA 0.3 0.00069 to 0.0021 2002
Second Generation
454 GS20 200 100 SE, PE indel 1 0.02 2005
454 GS FLX 400 250 SE, PE indel 1 0.1 2007
454 GS FLX Titanium 1M 450 SE, PE indel 1 0.45 2009
454 GS FLX 1M 700 SE, PE indel 1   2011
Titanium+ 0.7
454 GS Junior 100 400 SE, PE indel 1 0.04 2010
454 GS Junior+ 100 700 SE, PE indel 1 0.07 2014
Illumina MiniSeq 25M (maximum) 150 SE, PE mismatch 1 7.5 (maximum) 2013
Illumina MiSeq 25M (maximum) 300 SE, PE mismatch 0.1 15 (maximum) 2011
Illumina NextSeq 400M (maximum) 150 SE, PE mismatch 1 120 (maximum) 2014
Illumina HiSeq 5B (maximum) 150 SE, PE mismatch 0.1 1.5Tb (maximum) 2012
Illumina HiSeq X 6B (maximum) 150 SE, PE mismatch 0.1 1.8Tb (maximum) 2014
SOLiD 5500 W 3B 75 SE mismatch ~0.1 160 2011
SOLiD 5500xl W 6B 75 SE mismatch ~0.1 320 2013
Ion Torrent PGM 314 chip v2 400.000-550.000 400 SE indel 1 0.06 to 0.1 2011
Ion Torrent PGM 316 chip v2 2M - 3M 200 SE indel 1 0.6 to 1 2011
Ion Torrent PGM 318 chip v2 4M - 5.5M 400 SE indel 1 1.2 to 2 2013
Ion Torrent Ion Proton 60M - 80M 200 SE indel 1 10 2012
Ion Torrent Ion S5/S5XL 520 3M - 5M 400 SE indel 1 1.2 to 2 2015
Ion Torrent Ion S5/S5XL 530 15M-20M 400 SE indel 1 03 to 05 2015
Ion Torrent Ion S5/S5XL 540 60M - 80M 400 SE indel 1 NA 2015
Third Generation
PacBio RS C1 432 1300 SE indel 15 0.54 2011
PacBio RS C2 432 2500 SE indel 15 0.5 to 1 2012
PacBio RS C2 XL 432 4300 SE indel 15 0.5 to 1 2012
PacBio RS II C2 XL 564 4600 SE indel 15 0.5 to 1 2013
PacBio RS II P5 C3 528 8500 SE indel 13 0.5 to 1 2014
PacBio RS II P6 C4 660 13500 SE indel 12 0.5 to 1 2014
PacBio Sequel 350 10000 SE NA NA 7 2016
Oxford Nanopore MinION Mk 100 9545 1D,2D indel/mismatch 12 1.5 2015
Oxford Nanopore PromethION NA 9846 1D,2D NA NA 2Tb to 4Tb 2016

Table 1: Summary of NGS platforms and characteristics.

The First Generation of Sequencing

Sanger and Maxam-Gilbert sequencing technologies were classified as the First Generation Sequencing Technology [10,16] who initiated the field of DNA sequencing with their publication in 1977.

Sanger sequencing

Sanger Sequencing is known as the chain termination method or the dideoxynucleotide method or the sequencing by synthesis method. It consists in using one strand of the double stranded DNA as template to be sequenced. This sequencing is made using chemically modified nucleotides called dideoxy-nucleotides (dNTPs). These dNTPs are marked for each DNA bases by ddG, ddA, ddT, and ddC. The dideoxynucleotides are used dNTPs are used for elongation of nucleotide, once incorporated into the DNA strand they prevent the further elongation and the elongation is complete. Then, we obtain DNA fragments ended by a dNTP with different sizes. The fragments are separated according to their size using gel slab where the resultant bands corresponding to DNA fragments can be visualized by an imaging system (X-ray or UV light) [24,25]. Figure 1 details the Sanger sequencing technology.


Figure 1: Sanger sequencing technology. (a) The sequencing reaction is performed by the presence of denatured DNA template, radioactively labeled primer, DNA polymerase, and dNTPs. The DNA polymerase is used to incorporate the dNTPs into the elongating DNA strand. Each of the four dNTPs is run in a separate reaction so the polymerization can randomly terminate at each base position. The end result of each reaction is a population of DNA fragments with different lengths, with the length of each fragment dependent on where the dNTPs is incorporated. (b) Illustrates the separation of these DNA fragments in a denaturing gel by electrophoresis. The radioactive labeling on the primer enables visualization of the fragments as bands on the gel. The bands on the gel represent the respective fragments shown to the right. The complement of the original template (read from bottom to top) is given on the left margin of the sequencing gel. (From P Moran, Overview of commonly used DNA techniques, in LK Park, P Moran, and RS Waples, eds., Application of DNA Technology to the Management of Pacific Salmon, 1994, 15–26, Department of Commerce, NOAA Technical Memorandum NMFS-NWFSC-17. © Paul Moran, NOAA’s Northwest Fisheries Science Center. With permission).

The first genomes sequenced by the Sanger sequencing are phiX174 genome with size of 5374 bp [26] and in 1980 the bacteriophage λ genome with length of 48501 bp [27]. After years of improvement, Applied Biosystems is the first company that has automated Sanger sequencing. Applied Biosystems has built in 1995 an automatic sequencing machine called ABI Prism 370 based on capillary electrophoresis allowing fast an accurate sequencing. The Sanger sequencing was used in several sequencing projects of different plant species such as Arabidopsis [28], rice [29] and soybean [30] and the most emblematic achievement of this sequencing technology is the decoding of the first human genome [31].

The sanger sequencing was widely used for three decades and even today for single or low-throughput DNA sequencing, however, it is difficult to further improve the speed of analysis that does not allow the sequencing of complex genomes such as the plant species genomes and the sequencing was still extremely expensive and time consuming.

Maxam-Gilbert sequencing

Maxam-Gilbert is another sequencing belonging to the first generation of sequencing known as the chemical degradation method. Relies on the cleaving of nucleotides by chemicals and is most effective with small nucleotides polymers. Chemical treatment generates breaks at a small proportion of one or two of the four nucleotide bases in each of the four reactions (C, T+C, G, A+G). This reaction leads to a series of marked fragments that can be separated according to their size by electrophoresis [5,24].

The sequencing here is performed without DNA cloning. However, the development and improvement of the Sanger sequencing method favored the latter to the Maxam-Gilbert sequencing method, and it is also considered dangerous because it uses toxic and radioactive chemicals.

The Second Generation of Sequencing

The first generation of sequencing was dominant for three decades especially Sanger sequencing, however, the cost and time was a major stumbling block. In 2005 and in subsequent years, have marked the emergence of a new generation of sequencers to break the limitations of the first generation. The basic characteristics of second generation sequencing technology are: (1) The generation of many millions of short reads in parallel, (2) The speed up of sequencing the process compared to the first generation, (3) The low cost of sequencing and (4) The sequencing output is directly detected without the need for electrophoresis.

Short read sequencing approaches divided under two wide approaches: sequencing by ligation (SBL) and sequencing by synthesis (SBS), (more details for these sequencing categories are presented in [22,32]) and are mainly classified into three major sequencing platforms: Roche/454 launched in 2005, Illumina/Solexa in 2006 and in 2007 the ABI/SOLiD. We will briefly describe these commonly utilized sequencing platforms.

Roche/454 sequencing

Roche/454 sequencing appeared on the market in 2005, using pyrosequencing technique which is based on the detection of pyrophosphate released after each nucleotide incorporation in the new synthetic DNA strand ( The pyrosequencing technique is a sequencing-by-synthesis approach.

DNA samples are randomly fragmented and each fragment is attached to a bead whose surface carries primers that have oligonucleotides complementary to the DNA fragments so each bead is associated with a single fragment (Figure 2A). Then, each bead is isolated and amplified using PCR emulsion which produces about one million copies of each DNA fragment on the surface of the bead (Figure 2B). The beads are then transferred to a plate containing many wells called picotiter plate (PTP) and the pyrosequencing technique is applied which consists in activating of a series of downstream reactions producing light at each incorporation of nucleotide. By detecting the light emission after each incorporation of nucleotide, the sequence of the DNA fragment is deduced (Figure 2C) [15]. The use of the picotiter plate allows hundreds of thousands of reactions occur in parallel, considerably increasing sequencing throughput [14]. The latest instrument launched by Roche/454 called GS FLX+ that generates reads with lengths of up to 1000 bp and can produce ~1Million reads per run ( GS FLX+Systems index.asp). Other characteristics of Roche/454 instruments are listed in [16,25].


Figure 2: Roche/454 sequencing technology [39].

The Rche/454 is able to generate relatively long reads which are easier to map to a reference genome. The main errors detected of sequencing are insertions and deletions due to the presence of homopolymer regions [33,34]. Indeed, the identification of the size of homopolymers should be determined by the intensity of the light emitted by pyrosequencing. Signals with too high or too low intensity lead to under or overestimation of the number of nucleotides which causes errors of nucleotides identification.

Ion torrent sequencing

Life Technologies commercialized the Ion Torrent semiconductor sequencing technology in 2010 ( home/brands/ion-torrent.html). It is similar to 454 pyrosequencing technology but it does not use fluorescent labeled nucleotides like other second-generation technologies. It is based on the detection of the hydrogen ion released during the sequencing process [35].

Specifically, Ion Torrent uses a chip that contains a set of micro wells and each has a bead with several identical fragments. The incorporation of each nucleotide with a fragment in the pearl, a hydrogen ion is released which change the pH of the solution. This change is detected by a sensor attached to the bottom of the micro well and converted into a voltage signal which is proportional to the number of nucleotides incorporated (Figure 3).


Figure 3: Ion torrent sequencing technology [22].

The Ion Torrent sequencers are capable of producing reads lengths of 200 bp, 400 bp and 600 bp with throughput that can reach 10 Gb for ion proton sequencer. The major advantages of this sequencing technology are focused on read lengths which are longer to other SGS sequencers and fast sequencing time between 2 and 8 hours. The major disadvantage is the difficulty of interpreting the homopolymer sequences (more than 6 bp) [21,36] which causes insertion and deletion (indel) error with a rate about ~1%.

Illumina/Solexa sequencing

The Solexa company has developed a new method of sequencing. Illumina company ( purchased Solexa that started to commercialize the sequencer Ilumina/Solexa Genome Analyzer (GA) [3,37]. Illumina technology is sequencing by synthesis approach and is currently the most used technology in the NGS market.

The sequencing process is shown in Figure 4. During the first step, the DNA samples are randomly fragmented into sequences and adapters are ligated to both ends of each sequence. Then, these adapters are fixed themselves to the respective complementary adapters, the latter are hooked on a slide with many variants of adapters (complementary) placed on a solid plate (Figure 4A). During the second step, each attached sequence to the solid plate is amplified by “PCR bridge amplification” that creates several identical copies of each sequence; a set of sequences made from the same original sequence is called a cluster. Each cluster contains approximately one million copies of the same original sequence (Figure 4B). The last step is to determine each nucleotide in the sequences, Illumina uses the sequencing by synthesis approach that employs reversible terminators [38] in which the four modified nucleotides, sequencing primers and DNA polymerases are added as a mix, and the primers are hybridized to the sequences. Then, polymerases are used to extend the primers using the modified nucleotides. Each type of nucleotide is labeled with a fluorescent specific in order for each type to be unique. The nucleotides have an inactive 3’-hydroxyl group which ensures that only one nucleotide is incorporated. Clusters are excited by laser for emitting a light signal specific to each nucleotide, which will be detected by a coupled-charge device (CCD) camera and Computer programs will translate these signals into a nucleotide sequence (Figure 4C). The process continues with the elimination of the terminator with the fluorescent label and the starting of a new cycle with a new incorporation [21,39].


Figure 4: Illumina sequencing technology [39].

The first sequencers Illumina/Solexa GA has been able to produce very short reads ~35 bp and they had an advantage in that they could produce paired-end (PE) short reads, in which the sequence at both ends of each DNA cluster is recorded. The output data of the last Illumina sequencers is currently higher than 600 Gpb and lengths of short reads are about 125 bp. Details on Illumina sequencers [13].

One of the main drawbacks of the Illumina/Solexa platform is the high requirement for sample loading control because overloading can result in overlapping clusters and poor sequencing quality. The overall error rate of this sequencing technology is about 1%. Substitutions of nucleotides are the most common type of errors in this technology [40], the main source of error is due to the bad identification of the incorporated nucleotide.

ABI/SOLiD sequencing

Supported Oligonucleotide Ligation and Detection (SOLiD) is a NGS sequencer Marketed by Life Technologies (http:// In 2007, Applied Biosystems (ABI) has acquired SOLiD and developed ABI/SOLID sequencing technology that adopts by ligation (SBL) approach [3].

The ABI/SOLiD process consists of multiple sequencing rounds. It starts by attaching adapters to the DNA fragments, fixed on beads and cloned by PCR emulsion. These beads are then placed on a glass slide and the 8-mer with a fluorescent label at the end are sequentially ligated to DNA fragments, and the color emitted by the label is recorded (Figure 5A). Then, the output format is color space which is the encoded form of the nucleotide where four fluorescent colors are used to represent 16 possible combinations of two bases. The sequencer repeats this ligation cycle and each cycle the complementary strand is removed and a new sequencing cycle starts at the position n-1 of the template. The cycle is repeated until each base is sequenced twice (Figure 5B). The recovered data from the color space can be translated to letters of DNA bases and the sequence of the DNA fragment can be deduced [15].


Figure 5: ABI/SOLID sequencing technology [39].

ABI/SOLiD launched the first sequencer that produce short reads with length 35 bp and output of 3 Gb/run and continued to improve their sequencing which increased the length of reads to 75 bp with an output up to 30 Gb/run [22,23]. The strength of ABI/SOLiD platform is high accuracy because each base is read twice while the drawback is the relatively short reads and long run times. The errors of sequencing in this technology is due to noise during the ligation cycle which causes error identification of bases. The main type of error is substitution.

The Third Generation of Sequencing

The second-generation of sequencing technologies previously discussed have revolutionized the analysis of DNA and have been the most widely used compared to the first generation of sequencing technologies. However, the SGS technologies generally require PCR amplification step which is a long procedure in execution time and expansive in sequencing price. Also, it became clear that the genomes are very complex with many repetitive areas that SGS technologies are incapable to solve them and the relatively short reads made genome assembly more difficult. To remedy the problems caused by SGS technologies, scientists have developed a new generation of sequencing called “third generation sequencing”. These third generations of sequencing have the ability to offer a low sequencing cost and easy sample preparation without the need PCR amplification in an execution time significantly faster than SGS technologies. In addition, TGS are able to produce long reads exceeding several kilobases for the resolution of the assembly problem and repetitive regions of complex genomes.

There are two main approaches that characterize TGS [22]: The single molecule real time sequencing approach (SMRT) [38] that was developed by Quake laboratory [41-43] and the synthetic approach that rely on existing short reads technologies used by Illumina (Moleculo) [43] and 10xGenomics ( to construct long reads. The most widely used TGS technology approach is SMRT and the sequencers that have used this approach are Pacific Biosciences and Oxford Nanopore sequencing (specifically the MinION sequencer).

In the following, we present the two most widely used sequencing platforms in TGS to know Pacific Biosciences and the MinION sequencing from Oxford Nanopore technology.

Pacific biosciences SMRT sequencing

Pacific Biosciences ( developed the first genomic sequencer using SMRT approach and it’s the most widely used third-generation sequencing technology.

Pacific Biosciences uses the same fluorescent labelling as the other technologies, but instead of executing cycles of amplification nucleotide, it detects the signals in real time, as they are emitted when the incorporations occur. It uses a structure composed of many SMRT cells, each cell contains microfabricated nanostructures called zeromode waveguides (ZMWs) which are wells of tens of nanometers in diameter microfabricated in a metal film which is in turn deposited onto a glass substrate [44,45]. These ZMWs exploit the properties of light passing through openings with a diameter less than its wavelength, so light cannot be propagated. Due to their small diameter, the light intensity decreases along the wells and the bottom of the wells illuminated (Figure 6A). Each ZMW contains a DNA polymerase attached to their bottom and the target DNA fragment for sequencing. During the sequencing reaction, the DNA fragment is incorporated by the DNA polymerase with fluorescent labeled nucleotides (with different colors). Whenever a nucleotide is incorporated, it releases a luminous signal that is recorded by sensors (Figure 6B). The detection of the labeled nucleotides makes it possible to determine the DNA sequence.


Figure 6: Pacific biosciences sequencing technology [39].

Compared to SGS, Pacific Bioscience technology has several advantages. The preparation of the sample is very fast, it takes 4 to 6 hours instead of days [16]. In addition, the long-read lengths, currently averaging ~10 kbp [46] but individual very long reads can be as long as 60 kbp, which is longer than that of any SGS technology. Pacific Biosciences sequencing platforms have a high error rate of about 13% [13] dominated by insertions and deletions errors. These errors are randomly distributed along the long read [47].

Oxford nanopore sequencing

The Oxford Nanopore sequencing (ONT) was developed as a technique to determine the order of nucleotides in a DNA sequence. In 2014, Oxford Nanopore Technologies released the MinION [48] device that promises to generate longer reads that will ensure a better resolution structural genomic variants and repeat content [49]. It’s a mobile single-molecule Nanopore sequencing measures four inches in length and is connected by a USB 3.0 port of a laptop computer. This device has been released for testing by a community of users as part of the MinION Access Program (MAP) to examine the performance of the MinION sequencer [50].

In this sequencing technology, the first strand of a DNA molecule is linked by a hairpin to its complementary strand. The DNA fragment is passed through a protein nanopore (a nanopore is a nanoscale hole made of proteins or synthetic materials [39]). When the DNA fragment is translated through the pore by the action of a motor protein attached to the pore, it generates a variation of an ionic current caused by differences in the moving nucleotides occupying the pore (Figure 7A). This variation of ionic current is recorded progressively on a graphic model and then interpreted to identify the sequence (Figure 7B). The sequencing is made on the direct strand generating the “template read” and then the hairpin structure is read followed by the inverse strand generating the “complement read”, these reads is called "1D". If the “temple” and “complement” reads are combined, then we have a resulting consensus sequence called “two direction read” or "2D" [51,52].


Figure 7: Oxford nanopore MinION sequencing [21].

Among the advantages offered by this sequencer: first, it’s low cost and small size. Then, the sample is loaded into a port on the device and data is displayed on the screen and generated without having to wait till the run is complete. And, MinION can provide very long reads exceeding 150 kbp which can improve the contiguity of the denovo assembly. However, MinION produces a high error rate of ~12% distributed about ~3% mismatchs, ~4% insertions and ~5% deletions [53].

The ONT technology has continued to evolve. Recently, a new instrument has emerged called "PromethION"[54]; it is the bigger brother of the MinION [55]. It is an autonomous worktable sequencer with 48 individual flow cells each with 3000 pores (equivalent to 48 MinIONs) operating at 500 bp [51] per second which is sufficiently powerful to achieve an ultra-high throughput needed for sequencing large genomes such as the human genome. Although the PromethION is not commercially available, the ONT announces that it is capable of producing ~2 to 4 Tb for a duration of 2 days and a length of reads [22] which can attain 200 Kpb which puts this sequencer in competition with the PacBioRSII sequencer from pacific biosciences in terms of read length and HiSeq sequencer from Illumina in cost.


The first method of sequencing came about half a century ago, and since then, sequencing technologies have continued to evolve especially after the appearance of the first sequencers from NGS technology which appeared in 2005. These technologies are characterized by their high throughput which gives the opportunity to produce millions of reads with inexpensive sequencing. NGS technologies are now the starting point for several areas of research based on the study and analysis of biological sequences.

In this review, we presented a concise overview of the generations of sequencing technologies by beginning with the first-generation sequencing history followed by the main commonly used NGS platforms. Nevertheless, there are significant challenges in NGS technologies, including the difficulty of storing and analyzing the data generated by these technologies. This is mainly due to the production of a high number of reads. In the coming years, new sequencing platforms will appear producing a larger amount of data (in Terabyte) which requires the development of new approaches and applications capable of analyzing this large amount of data.

Conflict of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 15343
  • [From(publication date):
    May-2017 - Jan 20, 2019]
  • Breakdown by view type
  • HTML page views : 13894
  • PDF downloads : 1449

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2019-20
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

ankara escort

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

pendik escort

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2019 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version